Jessica C. Shand, M.D., M.H.S.

About Me

Dr. Shand cares for patients in the pediatric primary care practice and provides expert consultation as requested for patients with hematologic issues. She is involved in quality improvement efforts through the GCH Morbidity and Mortality Conference which she co-directs, and through development of a...

Dr. Shand cares for patients in the pediatric primary care practice and provides expert consultation as requested for patients with hematologic issues. She is involved in quality improvement efforts through the GCH Morbidity and Mortality Conference which she co-directs, and through development of anticoagulation best practices. She is an active scholar, focusing her recent work on the ethics of scarce resource utilization, and on improving health equity for patients with sickle cell disease. Dr. Shand serves as the Associate Director of the Resident Research Track and teaches in the DEI and Core Bioethics curricula. Dr. Shand holds a joint appointment in the Department of Health Humanities and Bioethics, where she serves at the Bioethics Pathway Director, teaches several courses in Bioethics, mentors students, and implements curriculum innovations at the intersection of ethics, health equity, and spiritual care. Dr. Shand also holds an institutional leadership role as the Director of the URMC Clinician and Faculty Wellbeing Program, bringing an interdisciplinary lens to improving clinician wellbeing through innovations in technology use and team debriefs.

Professional Background

Assistant Professor of Pediatrics
General Pediatrics

Certified Specialties

Pediatrics - American Board of Pediatrics

Faculty Appointments

Associate Professor - Department of Pediatrics, General Pediatrics (SMD)

Associate Professor - Department of Health Humanities and Bioethics (SMD) - Joint

Credentials

Residency & Fellowship

Fellowship, Pediatric Hematology-Oncology, Johns Hopkins University Pediatric Anesthesiology (USA). 2009 - 2012

Residency, Pediatrics, University of Rochester Medical Center. 2007 - 2009

Internship, Pediatrics, University of Rochester Medical Center. 2006 - 2007

Education

MD | University at Buffalo. 2006

Awards

Alpha Omega Alpha Faculty Inductee. 2016

AR Coalition™ Immuno Oncology Young Investigator Forum Second Place for Junior Faculty Basic Science (abstract competition). 2016

American Society for Blood and Marrow Transplantation/BBMT 2014. 2015 - 2015

Honorable Mention, Fellows' Research Day. 2012

American Society of Hematology Abstract Achievement Award. 2012

American Society of Hematology Abstract Achievement Award. 2011

Meg Colgan Award for Dedication to Underserved Children. 2009

American Society of Hematology Trainee Research Award. 2008 - 2009

Neonatal Intensive Care Unit Award. 2008

Arnold P. Gold Foundation Humanism in Medicine Honor Society. 2006

Howard Hughes Medical Institute Continuing Support Award. 2004 - 2006

Research

Dr. Shand has a background in translational hematology research, including pediatric leukemias with high-risk features. Her current research focuses on ethics and health equity issues in hematology, including ethical issues in blood management and therapeutic drug development, as well as bias/stigma...

Dr. Shand has a background in translational hematology research, including pediatric leukemias with high-risk features. Her current research focuses on ethics and health equity issues in hematology, including ethical issues in blood management and therapeutic drug development, as well as bias/stigma in the care of adolescents and young adults with sickle cell disease. Dr. Shand also has a scholarly interest on the impact of spiritual care and healthcare chaplaincy collaboration on outcomes of ethical dilemmas and community health equity.

Publications

Journal Articles

Successful reduced-intensity conditioning hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria with aplastic anemia in two children.

Andolina JR, Reinish AL, Akhtar R, Noronha S, Shand JC, Girvin A, Korones DN, Bruckner LB, Mullen CA, Curran KJ, Boulad F

Pediatric blood & cancer.. 2018 August 65 (8):e27218. Epub 05/03/2018.

"Existential Fridays"-reflection in action.

Shand JC

Pediatric blood & cancer.. 2018 June 65 (6):e27004. Epub 02/22/2018.

Looking up for AML in Down syndrome.

Shand JC

Blood.. 2017 June 22129 (25):3273-3274. Epub 1900 01 01.

One Giant Leap for AMKL

Shand JC.

Blood. 2016; 127(26): 3299-300.

Minor antigen distribution predicts site-specific graft-versus-tumor activity of adoptively transferred, minor antigen-specific CD8+ T Cells. PMCID: PMC3997266; PMID: 24141010.

Shand JC, Qin H, Nasholm N, Capitini CM and Fry TJ.

Biol Blood Marrow Transplant. 2014; 20(1): 26-36.

Transplantation genetics and genomics: Alloreactivity after hematopoietic stem cell transplantation. In: Murray MF, Babyatsky MW, Giovanni MA, Alkuraya FS, Stewart DR (eds).

Shand JC, Fry TJ.

Clinical Genomics: Practical Applications in Adult Patient Care (1st ed.), McGraw-Hill. 2014; 174.

AAP Policy Statement: Human Embryonic Stem Cell (HESC) and Human Embryo Research

Shand JC, Berg JL, Bogue CM, lead authors.

Pediatrics. 2012; 130: 1-6.

Differential gene expression in acute lymphoblastic leukemia cells surviving allogeneic transplant.

Shand JC, Jansson J, Hsu YC, Campbell A, Mullen CA

Cancer immunology, immunotherapy : CII.. 2010 November 59 (11):1633-44. Epub 07/03/2010.

Adolescents and young adults successfully restore lymphocyte homeostasis after intensive T-cell depleting therapy for cancer.

Shand JC, Mansky PJ, Brown MV, Fleisher TA, Mackall CL

British journal of haematology.. 2006 October 135 (2):270-1. Epub 1900 01 01.